Crutchlow, M. F., Palcza, J. S., Mostoller, K. M., Mahon, C. D., Barbour, A. M., Marcos, M. C., . . . Hompesch, M. (2017). Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK‐1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects. Diabetes Obes Metab.
Citación estilo ChicagoCrutchlow, Michael F., et al. "Single‐dose Euglycaemic Clamp Studies Demonstrating Pharmacokinetic and Pharmacodynamic Similarity between MK‐1293 Insulin Glargine and Originator Insulin Glargine (Lantus) in Subjects With Type 1 Diabetes and Healthy Subjects." Diabetes Obes Metab 2017.
Cita MLACrutchlow, Michael F., et al. "Single‐dose Euglycaemic Clamp Studies Demonstrating Pharmacokinetic and Pharmacodynamic Similarity between MK‐1293 Insulin Glargine and Originator Insulin Glargine (Lantus) in Subjects With Type 1 Diabetes and Healthy Subjects." Diabetes Obes Metab 2017.